FURESTEM-AD

· Kang Stem Biotech Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FURESTEM-AD, covering 2021-08-13 to 2021-08-13. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of FURESTEM-AD Inj. for Moderate to Severe Atopic Dermatitis (AD) [Phase 3]